DFA gives DOST info on COVID-19 vaccine development, clinical trials

Published July 10, 2020, 3:33 PM

by Roy Mabasa

The Department of Foreign Affairs (DFA) said on Friday it has already endorsed to the Department of Science and Technology (DOST) all the information they gathered on vaccine developments and potential international partners for COVID-19 (coronavirus disease 2019) clinical trials in the Philippines.


This came after the DFA, through its various embassies and consulates abroad, has initiated coordination and exchanges of information with different jurisdictions across the Americas, Asia and the Pacific, Europe, Africa, and the Middle East regarding the coronavirus vaccine developments.

Based on the information that has been gathered, the DFA has recommended that the following steps must be pursued to ensure that a viable vaccine can be made available and accessible to Filipinos: Collaboration with Philippine subsidiaries of vaccine developers; engagement with those overseas for the conduct of clinical trials; utilization of multilateral efforts to ensure vaccine access, and bilateral cooperation among countries.

The DOST chairs the sub-Technical Working Group on COVID-19 Vaccine Clinical Trials.

Apart from its efforts to obtain information on the development of vaccines worldwide, the DFA has also been engaged in processing and facilitating international humanitarian assistance for the government’s COVID-19 response.

As of this month, the DFA has processed and assisted in facilitation assistance from nine (9) foreign governments and six (6) of their medical agencies, four (4) international organizations, and 33 private companies, groups and individuals.